Aquatic Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-180,927
| Closed | -$2.4M | – | 1614 |
|
|
2024
Q4 | $2.4M | Buy |
180,927
+61,927
| +52% | +$820K | 0.06% | 333 |
|
|
2024
Q3 | $1.69M | Buy |
119,000
+53,800
| +83% | +$765K | 0.04% | 395 |
|
|
2024
Q2 | $844K | Sell |
65,200
-68,200
| -51% | -$883K | 0.03% | 426 |
|
|
2024
Q1 | $1.85M | Sell |
133,400
-2,600
| -2% | -$36.1K | 0.06% | 263 |
|
|
2023
Q4 | $1.94M | Buy |
136,000
+49,100
| +57% | +$701K | 0.05% | 338 |
|
|
2023
Q3 | $1.34M | Buy |
86,900
+43,900
| +102% | +$679K | 0.06% | 290 |
|
|
2023
Q2 | $676K | Buy |
+43,000
| New | +$676K | 0.04% | 387 |
|
|
2022
Q4 | – | Sell |
-34,400
| Closed | -$446K | – | 1807 |
|
|
2022
Q3 | $446K | Sell |
34,400
-18,100
| -34% | -$235K | 0.04% | 435 |
|
|
2022
Q2 | $737K | Buy |
+52,500
| New | +$737K | 0.24% | 117 |
|